Cell Biotech Co., Ltd. (KOSDAQ:049960)
South Korea · Delayed Price · Currency is KRW 15,840
+60 (0.38%)
At close: Sep 3, 2026
Cell Biotech Market Cap
Cell Biotech has a market cap or net worth of 108.13 billion as of September 4, 2026. Its market cap has increased by 25.80% in one year.
Market Cap
108.13B
Enterprise Value
11.91B
Revenue
60.40B
Ranking
n/a
PE Ratio
6.44
Stock Price
15,840.00
ChartMarket Cap Chart
Since March 3, 2003, Cell Biotech's market cap has increased from 13.97B to 108.13B, an increase of 674.15%. That is a compound annual growth rate of 9.09%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 3, 2026 | 108.41B | 20.82% |
| Dec 30, 2025 | 89.72B | -8.13% |
| Dec 30, 2024 | 97.66B | 27.18% |
| Dec 28, 2023 | 76.79B | -11.65% |
| Dec 29, 2022 | 86.92B | -34.80% |
| Dec 30, 2021 | 133.30B | -19.84% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Ensol Biosciences | 150.23B |
| ViGenCell | 149.23B |
| Prestige Biologics | 138.94B |
| ISU Abxis | 137.00B |
| Y-Biologics | 133.54B |
| TiumBio | 131.87B |
| CORESTEMCHEMON | 97.59B |
| Choong Ang Vaccine Laboratory | 86.37B |